Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial
- PMID: 19165664
- DOI: 10.1080/09513590802404013
Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial
Abstract
Aim: To compare donor and recipient outcome after inducing the final oocyte maturation with hCG or GnRH agonist in GnRH-antagonist treated oocyte donation (OD) cycles.
Methods: Two-hundred fifty-seven oocyte donors were enrolled to participate in a clinical trial in a private fertility centre. After stimulation with 225 IU rFSH and Cetrorelix 0.25 mg/day, 212 oocyte donors were randomised with sealed envelopes for triggering with recombinant hCG (Ovitrelle 250 microgr, n = 106) or a GnRH agonist (triptorelin 0.2 mg, n = 106).
Results: The number of retrieved COCs (12 +/- 6.3 vs 11.4 +/- 6.4), mature oocytes (8 +/- 4.6 vs 7.5 +/- 4.1), the proportion of mature oocytes (67.2 +/- 20.4% vs 67.1 +/- 20.9%) and fertilisation rates (67.8 +/- 23.5% vs 71.1 +/- 22.1%) were comparable. Clinical, ongoing pregnancy and live birth rates were not statistically different in the corresponding recipient groups. Nine cases of mild and one case of severe OHSS occurred in hCG group, whereas no cases were detected in GnRH agonist group.
Conclusions: The findings of our RCT suggest that donor and recipient outcome are comparable in OD cycles triggered with hCG or a GnRH agonist. Furthermore, the risk of OHSS seems to be reduced considerably, therefore the combination of a GnRH antagonist protocol with GnRH agonist triggering constitutes a safe treatment option for egg-donors.
Similar articles
-
Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.Fertil Steril. 2009 Feb;91(2):365-71. doi: 10.1016/j.fertnstert.2007.11.049. Epub 2008 Mar 25. Fertil Steril. 2009. PMID: 18367175
-
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology.Cochrane Database Syst Rev. 2014 Oct 31;2014(10):CD008046. doi: 10.1002/14651858.CD008046.pub4. Cochrane Database Syst Rev. 2014. PMID: 25358904 Free PMC article. Review.
-
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.Cochrane Database Syst Rev. 2011 Jan 19;(1):CD008046. doi: 10.1002/14651858.CD008046.pub3. Cochrane Database Syst Rev. 2011. Update in: Cochrane Database Syst Rev. 2014 Oct 31;(10):CD008046. doi: 10.1002/14651858.CD008046.pub4. PMID: 21249699 Updated. Review.
-
Comparison between a GnRH antagonist and a GnRH agonist flare-up protocol in oocyte donors: a randomized clinical trial.Hum Reprod. 2006 Sep;21(9):2246-51. doi: 10.1093/humrep/del152. Epub 2006 May 16. Hum Reprod. 2006. PMID: 16704995 Clinical Trial.
-
Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.Fertil Steril. 2013 Nov;100(5):1296-302. doi: 10.1016/j.fertnstert.2013.07.1976. Epub 2013 Aug 28. Fertil Steril. 2013. PMID: 23993928
Cited by
-
Revisiting ovarian hyper stimulation syndrome: Towards OHSS free clinic.J Hum Reprod Sci. 2015 Jan-Mar;8(1):13-7. doi: 10.4103/0974-1208.153120. J Hum Reprod Sci. 2015. PMID: 25838743 Free PMC article. Review.
-
GnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF/ICSI treatment cycles: Systematic review and meta-analysis.J Adv Res. 2015 May;6(3):341-9. doi: 10.1016/j.jare.2015.01.005. Epub 2015 Jan 21. J Adv Res. 2015. PMID: 26257931 Free PMC article. Review.
-
Random-start GnRH antagonist for emergency fertility preservation: a self-controlled trial.Int J Womens Health. 2015 Feb 12;7:219-25. doi: 10.2147/IJWH.S66743. eCollection 2015. Int J Womens Health. 2015. PMID: 25709506 Free PMC article.
-
Gonadotropin-releasing hormone agonist ovulation trigger-beyond OHSS prevention.Ups J Med Sci. 2020 May;125(2):138-143. doi: 10.1080/03009734.2020.1737599. Epub 2020 Mar 25. Ups J Med Sci. 2020. PMID: 32208810 Free PMC article. Review.
-
Use of gonadotropin-releasing hormone (GnRH) agonist trigger in fertility preservation for patients with inherited genetic disorders.Front Endocrinol (Lausanne). 2022 Sep 6;13:826419. doi: 10.3389/fendo.2022.826419. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36147559 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
